CDK2 and cancer: Previous studies have shown that flavonoids can inhibit CDK activity in human cancer cells in the nanomolar concentration range and structural studies show that CDK2 can form complexes with flavonoids (De Azevedo et al., 1996; Kaur et al., 1992).